phase readout
saveNCT02592317: A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Prostatic Neoplasms, Castration-Resistant
view source ↗
comments(0)
5-min edit window · permanent after that